Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach
About Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Daiichi Sankyo, Inc.
1
Debiopharm International SA
1
Eisai Limited
1
Intercept Pharmaceuticals
1
Ionis Pharmaceuticals, Inc.
1
Ipsen
1
Clinical Trials at Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach
During the past decade, Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
2004-09-01
2007-01-01
Terminated
43
The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
2006-02-01
2007-08-01
Completed
702
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-11-14
2020-05-25
Completed
358
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
2015-09-22
2025-09-01
Active, not recruiting
2,480
Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
2018-09-13
2021-04-02
Completed
43
Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice
2019-08-01
2023-03-26
Withdrawn
0
A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
2022-05-18
2025-02-01
Recruiting
30
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Daiichi Sankyo, Inc." with 1 trials
sponsored, "Debiopharm International SA" with 1 trials sponsored, "Eisai Limited" with 1 trials sponsored and "Intercept Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
Clinical Trials Conditions at Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach
According to Clinical.Site data, the most researched conditions in "Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach" are
"Acromegaly" (2 trials), "Ulcerative Colitis" (2 trials), "GEP-NET" (1 trials), "Neuroendocrine Tumors" (1 trials) and "Non Alcoholic Steatohepatitis (NASH)" (1 trials). Many other conditions were trialed in "Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach" in a lesser frequency.
Clinical Trials Intervention Types at Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach
Most popular intervention types in "Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Etrolizumab" (2 trials), "Placebo" (2 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "Debio 4126" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach
The vast majority of trials in "Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach" are
8 trials for "All" genders.
Clinical Trials Status at Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach
Currently, there are NaN active trials in "Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".